Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control

被引:314
作者
Bhaskara, Srividya [1 ]
Chyla, Brenda J. [1 ]
Amann, Joseph M. [1 ,2 ,3 ]
Knutson, Sarah K. [1 ]
Cortez, David [1 ,4 ]
Sun, Zu-Wen [1 ,4 ]
Hiebert, Scott W. [1 ,4 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
关键词
D O I
10.1016/j.molcel.2008.02.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone deacetylases (HDACs) are enzymes that modify key residues in histones to regulate chromatin architecture, and they play a vital role in cell survival, cell-cycle progression, and tumorigenesis. To understand the function of Hdac3(-/-), a critical component of the N-CoR/SMRT repression complex, a conditional allele of Hdac3 was engineered. Cre-recombinasemediated inactivation of Hdac3 led to a delay in cell-cycle progression, cell-cycle-dependent DNA damage, and apoptosis in mouse embryonic fibroblasts (MEFs). While no overt defects in mitosis were observed in Hdac3(-/-) MEFs, including normal H3Ser10 phosphorylation, DNA damage was observed in Hdac3(-/-) interphase cells, which appears to be associated with defective DNA double-strand break repair. Moreover, we noted that Hdac3(-/-) MEFs were protected from DNA damage when quiescent, which may provide a mechanistic basis for the action of HDAC inhibitors on cycling tumor cells.
引用
收藏
页码:61 / 72
页数:12
相关论文
共 58 条
  • [41] Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies
    O'Connor, OA
    Heaney, ML
    Schwartz, L
    Richardson, S
    Willim, R
    MacGregor-Cortelli, B
    Curly, T
    Moskowitz, C
    Portlock, C
    Horwitz, S
    Zelenetz, AD
    Frankel, S
    Richon, V
    Marks, P
    Kelly, WK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) : 166 - 173
  • [42] Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance
    Prasanth, SG
    Prasanth, KV
    Siddiqui, K
    Spector, DL
    Stillman, B
    [J]. EMBO JOURNAL, 2004, 23 (13) : 2651 - 2663
  • [43] Prives C, 1999, J PATHOL, V187, P112
  • [44] PURIFICATION AND CHARACTERIZATION OF CAF-I, A HUMAN CELL FACTOR REQUIRED FOR CHROMATIN ASSEMBLY DURING DNA-REPLICATION INVITRO
    SMITH, S
    STILLMAN, B
    [J]. CELL, 1989, 58 (01) : 15 - 25
  • [45] Expression of the AML-1 oncogene shortens the G1 phase of the cell cycle
    Strom, DK
    Nipp, J
    Westendorf, JJ
    Linggi, B
    Lutterbach, B
    Downing, JR
    Lenny, N
    Hiebert, SW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (05) : 3438 - 3445
  • [46] Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases
    Taddei, A
    Maison, C
    Roche, D
    Almouzni, G
    [J]. NATURE CELL BIOLOGY, 2001, 3 (02) : 114 - 120
  • [47] N-terminal region, C-terminal region, nuclear export signal, and deacetylation activity of histone deacetylase-3 are essential for the viability of the DT40 chicken B cell line
    Takami, Y
    Nakayama, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) : 16191 - 16201
  • [48] A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p
    Taunton, J
    Hassig, CA
    Schreiber, SL
    [J]. SCIENCE, 1996, 272 (5260) : 408 - 411
  • [49] QUANTITATIVE STUDIES OF GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES
    TODARO, GJ
    GREEN, H
    [J]. JOURNAL OF CELL BIOLOGY, 1963, 17 (02) : 299 - &
  • [50] Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4
    Verreault, A
    Kaufman, PD
    Kobayashi, R
    Stillman, B
    [J]. CELL, 1996, 87 (01) : 95 - 104